Referral Guidelines for Stage 1 Twin-Twin Transfusion Syndrome Trial

The Center for Fetal Diagnosis and Treatment (CFDT) at Children’s Hospital of Philadelphia is participating in a randomized controlled trial comparing conservative management and selective laser photocoagulation (SLPC) surgery in stage 1 twin-twin transfusion syndrome (TTTS). SLPC will be offered within 72 hours if a patient is randomized into the laser group.

Referral guidelines for physicians

The following circumstances have to be met to be eligible for the study:

  • TTTS Stage 1 as per Eurofetus criteria
  • Gestational age 16+0 < 26+0 (depending upon placental location)
  • Age > 18 years

A patient is not eligible for the study if she meets any of the following exclusion criteria:

  • Therapeutic amniocentesis/amnioreduction prior to referral
  • Short cervix < 15 mm on transvaginal ultrasound
  • Severe maternal discomfort
  • Preterm premature rupture of the membranes (PPROM)
  • Fetal malformation unrelated to TTTS
  • Follow-up is impossible
  • Triplets or other higher order multiple pregnancy

Comprehensive evaluation of each pregnancy is essential to determine if a patient qualifies for this clinical trial. To refer a patient or discuss a case, call us at 1-800-IN UTERO (468-8376) and ask to speak with a CFDT patient coordinator.

selective laser photocoagulation therapy illustration Selective laser photocoagulation is performed fetoscopically, under conscious sedation, to target and interrupt placental vascular communications between fetuses.

IRB #13-010724

Additional study details and criteria can be found on clinicaltrials.gov.

Pregnant Mom and Child

Choosing a Fetal Treatment Center

Know what questions to ask when considering fetal surgery so you can make an informed decision that is right for you and your baby.

Pregnant Mom and Child

What to Expect

From the moment of referral through delivery and postnatal care, your family can expect a supportive experience when you come to us with a diagnosis of a birth defect.